# Fenfluramine for Adult Dravet Patients

> **NCT05560282** · PHASE3 · TERMINATED · sponsor: **University Health Network, Toronto** · enrollment: 7 (actual)

## Conditions studied

- Dravet Syndrome
- Dravet Syndrome, Intractable

## Interventions

- **DRUG:** Fenfluramine

## Key facts

- **NCT ID:** NCT05560282
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-01-11
- **Primary completion:** 2025-05-13
- **Final completion:** 2025-05-13
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Study recruitment was too slow, not enough funds to sustain it.
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05560282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05560282, "Fenfluramine for Adult Dravet Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05560282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*